Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report. Lacy SE, Barrans SL, Beer PA, Painter D, et al. Blood 2020;135:1759-1771.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lacy SE, Barrans SL, Beer PA, Painter D, et al. Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report. Blood 2020;135:1759-1771.
PMID: 32187361